RELAPSED MULTIPLE MYELOMA
Clinical trials for RELAPSED MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for RELAPSED MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Three-Drug cocktail targets Hard-to-Treat myeloma
Disease control OngoingThis study tests a new combination of three drugs—belantamab mafodotin, carfilzomib, and dexamethasone—in people whose multiple myeloma has returned and is no longer responding to lenalidomide. The trial has two parts: first, finding the safest dose, then testing that dose in up …
Matched conditions: RELAPSED MULTIPLE MYELOMA
Phase: PHASE1, PHASE2 • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Experimental CAR-T therapy takes on Hard-to-Treat myeloma
Disease control OngoingThis early-phase trial is testing a new type of immune cell therapy called Anti-BCMA CAR-T cells in 5 adults with multiple myeloma that has come back or not responded to at least three prior treatments. The therapy involves collecting a patient's own immune cells, modifying them …
Matched conditions: RELAPSED MULTIPLE MYELOMA
Phase: PHASE1 • Sponsor: Thomas Martin, MD • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC